Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Muñoz-Fernández, S.
Right arrow Articles by Ferreira, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Muñoz-Fernández, S.
Right arrow Articles by Ferreira, A.
Related Collections
Right arrow Spondylarthropathies
Right arrow Immunogenetics
Right arrow Rheumatoid Arthritis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2001; 40: 1365-1369
© 2001 British Society for Rheumatology


Original Papers

Soluble HLA class I antigens in serum and synovial fluid from patients with rheumatoid arthritis and other arthropathies

S. Muñoz-Fernández, J. Martín1, E. Martín-Mola, M. C. García-Rodriguez1, M. Cantalejo, G. Fontán1 and A. Ferreira1

Rheumatology and
1 Immunology Units, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain

Objectives. To investigate the presence of soluble HLA class I (s-HLA) antigens in serum and synovial fluid (SF) from a large cohort of rheumatic patients.

Methods. We studied clinical and analytical data and serum samples from 300 patients [122 patients with rheumatoid arthritis (RA), 38 with osteoarthritis or osteoporosis, 29 with seronegative spondyloarthropathies, 45 patients with other rheumatic diseases] and 66 healthy controls. In addition, we studied 25 paired samples of serum and SF from these groups of subjects. In RA patients, we examined whether the levels of s-HLA in serum and SF were related to the activity of the disease.

Results. The mean concentrations of s-HLA molecules in serum were slightly higher in RA patients (1.2 µg/ml) than in the other four groups (1.08, 1.01, 1.09 and 0.94 µg/ml respectively). We found no correlation between serum s-HLA levels and any variable of inflammatory disease activity in RA patients. s-HLA molecules were found in SF and at levels that correlated with those found in serum (P=0.04; r=0.4). Furthermore, s-HLA levels were higher in SF from patients with RA (1.3 µg/ml) or crystal-induced arthritis (0.98 µg/ml) than in SF from those with osteoarthritis (0.38 µg/ml) (P<0.05 and P<0.005 respectively), and these levels were correlated inversely and significantly with the score on the visual analogue scale of pain (P=0.02), the number of painful joints (P=0.05) and the level of C-reactive protein (P=0.03) in RA patients.

Conclusions. This is the first report to demonstrate the presence of s-HLA molecules in SF at levels that correlate with serum levels. The mean levels of s-HLA molecules were significantly higher in SF from patients with RA and crystal-induced arthritis than in SF from cases of osteoarthritis, and correlated inversely with certain variables of disease activity in RA patients.

KEY WORDS: s-HLA, Arthritis, Rheumatoid arthritis.

Correspondence to: S. Muñoz Fernández, Servicio de Reumatología, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.